First Horizon Advisors, Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21
-55.3%
10.0%0.00%
Q2 2023$47
+11.9%
10.0%0.00%
Q1 2023$42
+10.5%
10.0%0.00%
Q4 2022$3810.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$01
-93.3%
0.00%
Q1 2022$0
-100.0%
15
-71.2%
0.00%
Q4 2021$2,0000.0%520.0%0.00%
Q3 2021$2,000
+100.0%
52
+173.7%
0.00%
Q2 2021$1,00019
+90.0%
0.00%
Q1 2021$0
-100.0%
10
-95.6%
0.00%
-100.0%
Q4 2019$16,000
-48.4%
2260.0%0.00%
-50.0%
Q3 2019$31,000
-22.5%
2260.0%0.00%
-33.3%
Q2 2019$40,000
+14.3%
2260.0%0.00%0.0%
Q1 2019$35,000
+105.9%
226
+25.6%
0.00%
+50.0%
Q4 2018$17,000
-29.2%
1800.0%0.00%0.0%
Q3 2018$24,000
-11.1%
1800.0%0.00%0.0%
Q2 2018$27,000
+237.5%
180
+221.4%
0.00%
+100.0%
Q1 2018$8,000560.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders